Plan B One-steplevonorgestrel
According to the FDA label: Use for women to reduce chance of pregnancy after unprotected sex (if a contraceptive failed or if you did not use birth control)
38,450 adverse event reports submitted to the FDA (2004–2026)
Top Reported Adverse Events
The most frequently reported events in association with Plan B One-step in the FAERS database. These are events reported by patients taking this medication, not necessarily caused by it. A single report may include multiple events.
Show these terms with plain-language definitions
Tap any term below for a plain-language definition.
- Menstruation Irregular 13,231 reports
Vaginal Haemorrhage 6,805 reports
Vaginal bleeding, particularly heavy or unexpected bleeding. Also spelled hemorrhage in American English.
Full definition in the glossary →Nausea 4,445 reports
The feeling of sickness in your stomach that often comes before vomiting.
Full definition in the glossary → See all drugs reporting this event →- Menstruation Delayed 4,399 reports
- Dysmenorrhoea 3,363 reports
Vomiting 2,930 reports
Throwing up the contents of the stomach.
Full definition in the glossary → See all drugs reporting this event →- Pelvic Pain 2,206 reports
Headache 2,098 reports
Pain in the head or upper neck.
Full definition in the glossary → See all drugs reporting this event →Fatigue 1,857 reports
Extreme tiredness or lack of energy that does not improve with rest.
Full definition in the glossary → See all drugs reporting this event →Drug Ineffective 1,725 reports
A report that the medication did not work as expected for the person taking it. This is a reporting category, not a sign the drug is defective. It simply means someone felt it was not helping their condition.
Full definition in the glossary →- Pregnancy After Post Coital Contraception 1,720 reports
Dizziness 1,696 reports
A feeling of being lightheaded, unsteady, or like the room is spinning.
Full definition in the glossary → See all drugs reporting this event →Abdominal Pain 1,521 reports
Pain in the belly or stomach area.
Full definition in the glossary → See all drugs reporting this event →- Breast Tenderness 1,477 reports
- Vaginal Discharge 1,467 reports
Ranked by frequency of reports, not severity. The most-reported event is not necessarily the most dangerous or the most common in patients taking this drug.
Who Is Reporting
Demographics of patients in FAERS reports that included this information. Not all reports include patient demographics.
By Sex
View reporter sex data as a table
| Sex | Reports |
|---|---|
| Female | 38,123 |
| Male | 44 |
| Unknown | 40 |
By Age Group
View age group data as a table
| Age group | Reports |
|---|---|
| 0-17 | 1,900 |
| 18-34 | 12,462 |
| 35-49 | 2,181 |
| 50-64 | 157 |
| 65-74 | 8 |
| 75+ | 4 |
This shows who filed reports, reflecting who takes this drug and who tends to report, not who is at greatest risk.
Reported Outcomes
Outcomes recorded in FAERS reports that included Plan B One-step. A single report may involve multiple reactions, each with a different outcome. These categories are defined by FDA reporting guidelines, not by PillSignal.
View outcome data as a table
| Outcome | Reports |
|---|---|
| Non-Serious | 34,367 |
| Other Serious | 3,637 |
| Hospitalization | 650 |
| Life-Threatening | 134 |
| Disability | 101 |
| Death | 58 |
Serious outcomes are far more likely to be reported than mild ones, so this overstates how often outcomes are serious. A recorded death does not mean the drug caused it.
Report Volume Over Time
Number of FAERS reports received per quarter for Plan B One-step. Changes in volume may reflect shifts in prescribing rates, media attention, or reporting behavior, not changes in the medication's safety profile.
View report trend as a table
| Year | Reports |
|---|---|
| 2004 | 39 |
| 2005 | 39 |
| 2006 | 37 |
| 2007 | 27 |
| 2008 | 22 |
| 2009 | 50 |
| 2010 | 85 |
| 2011 | 6,105 |
| 2012 | 4,980 |
| 2013 | 4,225 |
| 2014 | 4,305 |
| 2015 | 3,556 |
| 2016 | 3,120 |
| 2017 | 2,159 |
| 2018 | 1,459 |
| 2019 | 2,247 |
| 2020 | 1,817 |
| 2021 | 533 |
| 2022 | 1,072 |
| 2023 | 889 |
| 2024 | 863 |
| 2025 | 694 |
| 2026 (partial) | 127 |
The steep increase around 2004 reflects the FDA's move to electronic submission, not a change in this drug's safety. Trends track reporting volume, not risk.
Related Drugs
Other medications with similar adverse event profiles in FDA FAERS reports.
Data Source
This data is sourced from the FDA's Adverse Event Monitoring System (AEMS), formerly FAERS, via the OpenFDA API. PillSignal is not affiliated with the FDA.
View this data on the FDA website →Data last updated: June 2026